Join FDA, researchers, clinicians, and innovators for a free, one-day virtual workshop open to the public focused on emerging scientific and regulatory pathways for advancing surrogate endpoints in rare disease drug development. This workshop is being offered as part of FDA’s Rare Disease Endpoint Advancement Pilot Program. CME credit will be available.